Cancer Vaccines Market by Treatment (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), and Indication (Cervical Cancer, Prostate Cancer), Vaccine Type (Recombinant Cancer Vaccine, Dendritic Cells Cancer Vaccine, Whole Cell Cancer Vaccine, Viral Vector and DNA Cancer Vaccine and Antigen/Adjuvant Cancer Vaccine), End User (Adults and Pediatrics) – Market Size & Forecast, 2019-2030

Report ID : 209  |  Published Date : Jan 2020  |  Pages : 170  |  Region : Global  |  Report Code : PH-13





Cancer Vaccines Market Overview and Introduction                   

Vaccines are biological products which help the body to fight diseases. These drugs train the immune system of an individual to recognize a foreign antigen and destroy the same in case of any encounter. In majority of cases, cancer cells have certain distinct molecules on its surface, known as cancer-specific antigens. The immune system gets simulated when these cells are introduced in the body of an individual, who has already been administered with a vaccine. Cancer vaccines can majorly be classified into two types, viz. prevention vaccines and treatment or therapeutic vaccines.

Several factors have triggered the need for appropriate vaccines to both prevent and treat cancers. Growing application of Human Papillomavirus (HPV) & hepatitis B vaccines for prevention from cancer-causing viruses, has been one of the most prominent factors contributing to the growth of the global vaccines market. Similarly, rising cases of cancers worldwide has also propelled the need for vaccines to these conditions. Moreover, growing focus on R&D, increasing investments & funding and, supportive government research for cancer treatments and increasing number of clinical trials have been pivotal in augmenting the growth of the global cancer vaccines. However, high cost Involved in vaccine development and high risks and uncertainty involved in vaccine production are few of the factors which may restrain the growth of the market to a certain extent.

The global cancer vaccines market is majorly classified into three segments, viz. by treatment, indication, vaccine type, end user and region.

Cancer Vaccines Market by Treatment

The segment of treatment can be further categorized as, preventive cancer vaccines and therapeutic cancer vaccines.

Cancer Vaccines Market by Indication

On the basis of product, the cancer vaccines market is bifurcated into three segments, i.e., cervical cancer, prostate cancer and other indications

Cancer Vaccines Market by Vaccine Type

On the basis of vaccine type, the cancer vaccines market is bifurcated into the following segments, i.e., recombinant cancer vaccine, dendritic cells cancer vaccine, whole cell cancer vaccine, viral vector and DNA cancer vaccine and antigen/adjuvant cancer vaccine.

Cancer Vaccines Market by End User

On the basis of end user, cancer vaccines market has be classified into adults, and pediatrics. The pediatric segment is expected to account for the largest share in the global cancer vaccines market. The large share of this segment can be attributed to growing trend of administering prophylactic vaccines among the pediatric population. 

Cancer Vaccines Market by Region

The global cancer vaccines market can be segmented into North America, Asia Pacific, Europe and Rest of World (ROW). North America dominated the global cancer vaccines market in 2019, owing to factors such as availability of favorable health insurance policies or schemes, high funding & investments for R&D of novel drugs, supportive government regulations, and presence of a large pool of patients suffering from a wide range of cancers among others.

Cancer Vaccines Market Prominent Players

The prominent players operating in the global cancer vaccines market are AstraZeneca, Bavarian Nordics, GlaxoSmithKline, Pfizer Inc., CSL Limited, Sanofi Pasteur, Merck & Co., Inc., Bristol-Myers Squibb, Astellas Pharma Inc., Aduro BioTech, Inc., and Dendreon

Table of Contents

  1. INTRODUCTION
    1. Market Definition
    2. Market Classification
    3.  Geographic Scope
    4.  Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecasted Years – 2019 to 2030
    5. Currency Used
  2. RESEARCH METHODOLOGY
    1. Research Framework
    2. Data Collection Technique
    3. Data Sources
      1.  Secondary Sources
      2. Primary Sources
    4. Market Estimation Methodology
      1.  Bottom Up Approach
      2.  Top Down Approach
    5. Data Validation and Triangulation
      1.  Market Forecasting Model
      2.  Limitations/Assumptions of the Study
  3. ABSTRACT OF THE STUDY
  4. MARKET DYNAMICS ASSESMENT
    1. Overview
    2. Drivers
    3. Barriers/Challenges
    4. Opportunities
  5. UNIQUE SELLING PROPOSITIONS (USPs)
    1. Product Pipeline Assessment
    2. Clinical Trials Assessment
    3. Epidemiological Assessment: Cancer Disease
  6. GLOBAL CANCER VACCINES MARKET - ANALYSIS & FORECAST, BY TREATMENT
    1. Preventive Cancer Vaccines          
    2. Therapeutic Cancer Vaccines
  7. GLOBAL CANCER VACCINES MARKET - ANALYSIS & FORECAST, BY INDICATION  
    1. Cervical Cancer
    2. Prostate Cancer
    3. Other Indications
  8. GLOBAL CANCER VACCINES MARKET - ANALYSIS & FORECAST, BY VACCINE TYPE
    1. Recombinant Cancer Vaccine
    2. Dendritic Cells Cancer Vaccine
    3. Whole Cell Cancer Vaccine
    4. Viral Vector And DNA Cancer Vaccine
    5. Antigen/Adjuvant Cancer Vaccine
  9. GLOBAL CANCER VACCINES MARKET - ANALYSIS & FORECAST, BY END USER
    1. Adults         
    2. Pediatrics
  10. GLOBAL CANCER VACCINES MARKET - ANALYSIS & FORECAST, BY REGION
    1.   North America Cancer Vaccines Market       
      1.  North America Cancer Vaccines  Market, By Country
        1.  US
        2.  Canada
      2. North America Cancer Vaccines Market Analysis & Forecast, By Treatment
      3. North America Cancer Vaccines Market Analysis & Forecast, By Indication
      4. North America Cancer Vaccines Market Analysis & Forecast, By Vaccine Type
      5. North America Cancer Vaccines Market Analysis & Forecast, By End User
    2. Europe Cancer Vaccines Market
      1. Europe cancer vaccines  Market, By Country/Region
        1. Germany
        2. U.K
        3. France
        4. Rest of Europe (ROE)
      2. Europe Cancer Vaccines Market Analysis & Forecast, By Treatment
      3. Europe Cancer Vaccines Market Analysis & Forecast, By Indication
      4. Europe Cancer Vaccines Market Analysis & Forecast, By Vaccine Type
      5. Europe Cancer Vaccines Market Analysis & Forecast, By End User
    3. Asia Pacific Cancer Vaccines Market
      1. Asia Pacific cancer vaccines Market, By Country/Region
        1. China
        2. Japan
        3. India
        4. Rest of Asia Pacific (RoAPAC)
      2. Asia Pacific Cancer Vaccines Market Analysis & Forecast, By Treatment
      3. Asia Pacific Cancer Vaccines Market Analysis & Forecast, By Indication
      4. Asia Pacific Cancer Vaccines Market Analysis & Forecast, By Vaccine Type
      5. Asia Pacific Cancer Vaccines Market Analysis & Forecast, By End User
    4.   Rest of the World (ROW) Cancer Vaccines Market
      1. Rest of the World cancer vaccines  Market, By Country/ Region
        1.  Latin America
        2.  Middle East & Africa
      2. Rest of the World Cancer Vaccines Market Analysis & Forecast, By Treatment
      3. Rest of the World Cancer Vaccines Market Analysis & Forecast, By Indication
      4. Rest of the World Cancer Vaccines Market Analysis & Forecast, By Vaccine Type
      5. Rest of the World Cancer Vaccines Market Analysis & Forecast, By End User
  11. COMPETETIVE LANDSCAPE
    1. Key Players & Their Competitive Positioning (2018)
    2. Key Strategies Assessment
      1. New Product Launches
      2. Merger & Acquisitions
      3. Agreements, Collaborations, & Partnerships
      4. Expansions
      5. Other Strategies
  12. COMPANY PROFILES (Business Overview, Products Offered, Financial Performance, Recent Developments)*
    1.   AstraZeneca
    2.   Bavarian Nordics
    3.   GlaxoSmithKline
    4.   Pfizer Inc.
    5.   CSL Limited
    6.   Sanofi Pasteur
    7.   Merck & Co., Inc.
    8.   Bristol-Myers Squibb
    9.   Astellas Pharma Inc.
    10.  Aduro BioTech, Inc.
    11.  Dendreon                  *Financial details might not be captured in case of privately-held companies or for companies that do not report this information in public domain